Edwards Lifesciences Corp (EW.N)

EW.N on New York Stock Exchange

153.10USD
1:36am IST
Change (% chg)

$-0.66 (-0.43%)
Prev Close
$153.76
Open
$153.59
Day's High
$154.99
Day's Low
$152.64
Volume
194,982
Avg. Vol
249,124
52-wk High
$158.93
52-wk Low
$89.46

EW.N

Chart for EW.N

About

Edwards Lifesciences Corporation is focused on technologies that treat structural heart disease and critically ill patients. The Company is engaged in the development and commercialization of heart valve therapies. It is a manufacturer of heart valve systems and repair products used to replace or repair a patient's diseased or... (more)

Overall

Beta: 0.74
Market Cap(Mil.): $16,538.08
Shares Outstanding(Mil.): 107.56
Dividend: --
Yield (%): --

Financials

Search Stocks

UPDATE 2-Edwards Lifesciences raises outlook on strong valve sales

July 28 - Edwards Lifesciences Corp on Tuesday raised its full-year profit forecast, citing strong demand for the medical device maker's replacement heart valves that are implanted in a minimally invasive procedure.

29 Jul 2015

Edwards Lifesciences raises outlook on strong valve sales

July 28 - Edwards Lifesciences Corp on Tuesday raised its full-year profit forecast due to strong demand for its replacement heart valves that are implanted in a minimally invasive procedure.

29 Jul 2015

Edwards Lifesciences to buy heart device maker for $400 million

(In July 10 story, corrects paragraph 6 to say "has reached an agreement on protocol revisions to restart enrollment" instead of "it would restart enrollment")

12 Jul 2015

CORRECTED-Edwards Lifesciences to buy heart device maker for $400 mln

July 10 - Edwards Lifesciences Corp said it would buy privately held heart device maker CardiAQ Valve Technologies Inc for up to $400 million to expand its portfolio of less-invasive mitral valve replacement devices.

12 Jul 2015

Edwards Lifesciences to buy heart device maker for $400 million

- Edwards Lifesciences Corp said it would buy privately held heart device maker CardiAQ Valve Technologies Inc for up to $400 million to expand its portfolio of less-invasive mitral valve replacement devices.

11 Jul 2015

Edwards Lifesciences to buy heart device maker for $400 mln

July 10 - Edwards Lifesciences Corp said it would buy privately held heart device maker CardiAQ Valve Technologies Inc for up to $400 million to expand its portfolio of less-invasive mitral valve replacement devices.

11 Jul 2015

Edwards gets U.S. approval for third generation heart valve

- The U.S. Food and Drug Administration on Wednesday said it approved Edwards Lifesciences Corp's Sapien 3 heart valve, the third-generation version of the company's system for replacing diseased aortic valves.

18 Jun 2015

UPDATE 1-Edwards gets U.S. approval for 3rd generation heart valve

June 17 - The U.S. Food and Drug Administration on Wednesday said it approved Edwards Lifesciences Corp's Sapien 3 heart valve, the third-generation version of the company's system for replacing diseased aortic valves.

18 Jun 2015

Edwards gets U.S. approval for 3rd generation heart valve

June 17 - The U.S. Food and Drug Administration on Wednesday said it approved Edwards Lifesciences Corp's Sapien 3 heart valve, the third-generation version of the company's system for replacing diseased aortic valves.

18 Jun 2015

Edwards stops small mitral heart valve study

- Edwards Lifesciences Corp on Tuesday said it stopped enrolling patients in a small study of its less-invasive mitral heart valve device due to the formation of blood clots associated with the procedure.

19 May 2015

Competitors

Earnings vs. Estimates

Search Stocks